跳至主要内容
临床试验/JPRN-UMIN000006605
JPRN-UMIN000006605已完成未知

Randomized study to compare olmesartan + azelnidipine versus valsartan + amlodipine to maximize blood pressure control and organ protection - The combination of olmesartan and azelnidipine in high-risk hypertensive patients

Kyoto Prefectural University School of Medicine0 个研究点目标入组 50 人开始时间: 2011年10月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients were excluded from the study if there was any evidence of secondary hypertension, renal failure (serum creatinine≥2.0mg/dl), severe liver dysfunction, symptomatic heart failure, and past history of cerebral infarction.

研究者

发起方
Kyoto Prefectural University School of Medicine

相似试验